No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 0.8x · 10Y median 0.9x · 17th percentile · as of Oct 6, 2026
Annual revenue · last 1 fiscal years + TTM
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T17:52:14.375Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T17:52:14.375Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T17:52:14.375Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T17:52:14.375Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T17:52:14.375Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T17:52:14.375Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T17:52:14.375Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Liberty Latin America Ltd. 9% Cum Perp Red Pfd Shs Series A When-issued (LILAP) stock was $20.64 as of Oct 6, 2026, 1:44 PM EDT, up 1.40% from the previous close.
Liberty Latin America Ltd., along with its affiliated entities, delivers a comprehensive suite of telecommunication services encompassing fixed-line, mobile, and subsea offerings. The company organizes its operations into several distinct units, namely C&W Caribbean and Networks, C&W Panama, Liberty Puerto Rico, VTR, and Costa Rica.
Telecommunications Services · Hamilton, HM
Next Earnings Date
Nov 11, 2026
36 days away
EPS Estimate
-0.01
Revenue Est.
$1.14B
Last Quarter Results
EPS
$-0.12
vs Estimate
$0.02
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1LILAP | $3.32B | $20.64 | +1.40% | N/A | N/A | N/A | N/A |
| 2BATRK | $3.33B | $52.35 | +0.35% | +26.94% | +14.28% | +11.60% | vs LILAP |
| 3RUM | $3.35B | $7.70 | +4.33% | -13.72% | -5.39% | N/A | vs LILAP |
| 4PPLI | $3.09B | $41.56 | -0.40% | +20.53% | -17.18% | +14.01% | vs LILAP |
| 5MGNI | $3.56B | $24.84 | -0.49% | +22.83% | -0.90% | +11.43% | vs LILAP |
| 6LBTYK | $3.01B | $8.84 | +0.40% | -25.76% | -10.87% | -6.54% | vs LILAP |
$1.10B
vs Estimate
$1.09B
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$20.64
High
N/A
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Quarter ending Dec 2026 | $0.09 | $0.09 | $0.09 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-0.19 | $-0.18 | $-0.18 | 1 |
| FY 2027 | $0.23 | $0.23 | $0.23 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $1.13B | $1.14B | $1.14B | 3 |
| Quarter ending Dec 2026 | $1.16B | $1.17B | $1.18B | 3 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $4.38B | $4.40B | $4.42B | 5 |
| FY 2027 |
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| $4.59B |
| $4.62B |
| $4.68B |
| 5 |
